Cargando…

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

Monoamine oxidase (MAO) metabolizes cytosolic dopamine (DA) thereby limiting auto-oxidation, but is also thought to generate cytosolic hydrogen peroxide (H(2)O(2)). We show that MAO metabolism of DA does not increase cytosolic H(2)O(2), but leads to mitochondrial electron transport chain (ETC) activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graves, Steven M., Xie, Zhong, Stout, Kristen A., Zampese, Enrico, Burbulla, Lena F., Shih, Jean C., Kondapalli, Jyothisri, Patriarchi, Tomasso, Tian, Lin, Brichta, Lars, Greengard, Paul, Krainc, Dimitri, Schumacker, Paul T., Surmeier, D. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257994/ https://www.ncbi.nlm.nih.gov/pubmed/31844313 http://dx.doi.org/10.1038/s41593-019-0556-3

Ejemplares similares

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
por: Guzman, Jaime N., et al.
Publicado: (2010)

Transient Activation of GABA(B) Receptors Suppresses SK Channel Currents in Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Estep, Chad M., et al.
Publicado: (2016)

Ca(2+) channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
por: Zampese, Enrico, et al.
Publicado: (2022)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

Maladaptive Downregulation of Autonomous Subthalamic Nucleus Activity following the Loss of Midbrain Dopamine Neurons
por: McIver, Eileen L., et al.
Publicado: (2019)

Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
por: Earley, Aaron M., et al.
Publicado: (2021)

α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
por: Lieberman, Ori J., et al.
Publicado: (2017)

Monoamine Oxidase and Dopamine β-Hydroxylase Inhibitors from the Fruits of Gardenia jasminoides
por: Kim, Ji Ho, et al.
Publicado: (2012)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
por: Brichta, Lars, et al.
Publicado: (2014)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Calcium, Bioenergetics, and Parkinson’s Disease
por: Zampese, Enrico, et al.
Publicado: (2020)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
por: Burbulla, Lena F., et al.
Publicado: (2021)

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson’s disease
por: Goldberg, Joshua A., et al.
Publicado: (2012)

Pharmacological Modulation of Behaviour, Serotonin and Dopamine Levels in Daphnia magna Exposed to the Monoamine Oxidase Inhibitor Deprenyl
por: Bellot, Marina, et al.
Publicado: (2021)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

3-Coumaranone derivatives as inhibitors of monoamine oxidase
por: Van Dyk, Adriaan S, et al.
Publicado: (2015)

Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018)

Cardiac monoamine oxidases: at the heart of mitochondrial dysfunction
por: Mialet-Perez, Jeanne, et al.
Publicado: (2020)

Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms
por: Phoswa, Wendy N.
Publicado: (2019)

In Vitro Human Monoamine Oxidase Inhibition and Human Dopamine D(4) Receptor Antagonist Effect of Natural Flavonoids for Neuroprotection
por: Paudel, Pradeep, et al.
Publicado: (2023)

Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington’s disease model mice
por: Pancani, Tristano, et al.
Publicado: (2023)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Androgen receptor and monoamine oxidase polymorphism in wild bonobos
por: Garai, Cintia, et al.
Publicado: (2014)

Inhibition of Monoamine Oxidase by Stilbenes from Rheum palmatum
por: Wei, Bo, et al.
Publicado: (2016)

Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?
por: Sommer, Natascha, et al.
Publicado: (2021)

Recent advances on the role of monoamine oxidases in cardiac pathophysiology
por: Kaludercic, Nina, et al.
Publicado: (2023)

Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma
por: Lee, Hui Min, et al.
Publicado: (2020)

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain
por: Cai, Lu, et al.
Publicado: (2016)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
por: Haj Ahmed, Wiem, et al.
Publicado: (2020)

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
por: Berlowitz, Ilana, et al.
Publicado: (2022)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

Monoamine Oxidase and its Inhibition. CIBA Foundation Symposium 39
por: Bowers, Malcolm B.
Publicado: (1978)

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors
por: Legoabe, Lesetja J, et al.
Publicado: (2015)

An Adrenal Mass and Increased Catecholamines: Monoamine Oxidase or Pheochromocytoma Effect?
por: Bosscher, Marianne R. F., et al.
Publicado: (2015)

“Ping-pong gaze” secondary to monoamine oxidase inhibitor overdose
por: Attaway, Amy, et al.
Publicado: (2016)

Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid
por: Khatri, Dharmendra Kumar, et al.
Publicado: (2016)

Regulatory Pathways of Monoamine Oxidase A during Social Stress
por: Higuchi, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ud5rjsehb5vi3aldvbcjot5dph